Search for media from: "Bharathi Vennapusa"

Media

33:15 FDA classifications & Development of In Vitro… FDA classifications & Development of In Vitro Diagnostic Assays	FDA classifications & Development of In Vitro Diagnostic Assays Review of FDA classification of IVD assays, overview of clinical trial process as well as IVD development including analytical validation. TE-US-01092 fda classification analytical validation clinical trials ivd development From Bharathi Vennapusa 0 likes 17 plays Content Declaration Keep for 3 Years Language (In English) English
17:00 Every Slide Tells a Story: Methods for Successful… Every Slide Tells a Story: Methods for Successful Immunohistochemical Staining	Every Slide Tells a Story: Methods for Successful Immunohistochemical Staining Review of preanalytic variables in immunohistochemical assay staining. TE-US-01089 preanalytics ihc assays From Bharathi Vennapusa 0 likes 7 plays Content Declaration Keep for 3 Years Language (In English) English
09:42 Low Prevalence Biomarkers: Validation Approach Low Prevalence Biomarkers: Validation Approach	Low Prevalence Biomarkers: Validation Approach Validation approach for low prevalence biomarkers and biomarkers in rare diseases for IHC assays. TE-US-01072 low prevalence biomarker validation From Bharathi Vennapusa 0 likes 5 plays Content Declaration Keep for 3 Years Language (In English) English
14:26 Assay Implementation: IHC Assays Assay Implementation: IHC Assays	Assay Implementation: IHC Assays Short video on implementing IHC assays in the anatomic pathology laboratory. TE-US-01071 ihc assays implementation From Bharathi Vennapusa 0 likes 6 plays Content Declaration Keep for 3 Years Language (In English) English
16:46 Validation and Verification: An Overview for IHC… Validation and Verification: An Overview for IHC Assays	Validation and Verification: An Overview for IHC Assays An overview of validation and verification of IHC in vitro diagnostic assays. TE-US-00990 validation verification ihc assays ivd From Bharathi Vennapusa 0 likes 15 plays Content Declaration Keep for 3 Years Language (In English) English
22:49 ER/PgR Testing in Breast Cancer: CAP/ASCO 2020… ER/PgR Testing in Breast Cancer: CAP/ASCO 2020 Guideline update	ER/PgR Testing in Breast Cancer: CAP/ASCO 2020 Guideline update Dr. Bharathi Vennapusa reviews CAP/ASCO 2020 guideline update for ER/PgR testing in breast cancer and how these guidelines pertain to Roche ER/PgR assays. er/pr cap asco guidelines From Bharathi Vennapusa 0 likes 6 plays Content Declaration Keep for 3 Years Language (In English) English
16:20 NTRK fusions: VENTANA pan-TRK (EPR17341) Assay NTRK fusions: VENTANA pan-TRK (EPR17341) Assay	NTRK fusions: VENTANA pan-TRK (EPR17341) Assay Drs. Bharathi Vennapusa, Denise Croix and Katie Robertson discuss overview of NTRK fusions, testing methods, algorithms with a focus on pan-TRK IHC assay using VENTANA pan-TRK (EPR17341) Assay. … From Bharathi Vennapusa 1 likes 9 plays Content Declaration Keep for 3 Years Language (In English) English
12:42 Scoring VENTANA HER2 Dual ISH DNA Probe Cocktail.… Scoring VENTANA HER2 Dual ISH DNA Probe Cocktail. Dr. Lynch	Scoring VENTANA HER2 Dual ISH DNA Probe Cocktail. Dr. Lynch In this short video, Roche Pathologist, Michael Lynch, M.D. reviews the scoring method for the VENTANA HER2 Dual ISH assay as well as discusses scoring challenges and potential pitfalls. breast her2+ her2 dual ish scoring From Bharathi Vennapusa 0 likes 9 plays Content Declaration Keep for 3 Years Language (In English) English
37:17 Tracking TRK with IHC: Today’s Diagnostic… Tracking TRK with IHC: Today’s Diagnostic Algorithms for NTRK Testing: CAP Today Webinar by Dr. Weiss	Tracking TRK with IHC: Today’s Diagnostic Algorithms for NTRK Testing: CAP Today Webinar by Dr. Weiss Recording for Dr. Lawrence Weiss's talk on CAP Today Webinar from December 1, 2020. Title: Tracking TRK with IHC: Today’s Diagnostic Algorithms for NTRK Testing TE-US-00983 ntrk cap today webinar From Bharathi Vennapusa 0 likes 14 plays Content Declaration Keep for 3 Years Language (In English) English
02:04 VENTANA HER2 Dual ISH DNA Probe Cocktail –… VENTANA HER2 Dual ISH DNA Probe Cocktail – Review of Scoring Algorithm	VENTANA HER2 Dual ISH DNA Probe Cocktail – Review of Scoring Algorithm Brief video on scoring algorithm for VENTANA HER2 Dual ISH DNA Probe Cocktail. Content and approvals of any product related information is current as of the date of publishing. TE-US-00939 From Bharathi Vennapusa 0 likes 7 plays Content Declaration Keep for 3 Years Language (In English) English
07:25 Remote Digital Pathology Devices - Guidance… Remote Digital Pathology Devices - Guidance During COVID-19 Pandemic	Remote Digital Pathology Devices - Guidance During COVID-19 Pandemic This video is an explainer of the recent relaxation of FDA and CMS guidance on digital pathology during the COVID19 pandemic. Roche Medical and Scientific Affairs representatives Drs. Bharathi… digital pathology covid-19 From Bharathi Vennapusa 0 likes 14 plays Content Declaration Keep for 3 Years Language (In English) English
10:39 How to score the PD-L1 (SP263) Assay in… How to score the PD-L1 (SP263) Assay in Urothelial Carcinoma	How to score the PD-L1 (SP263) Assay in Urothelial Carcinoma US Medical and Scientific Affairs (MSA) pathologist Dr. Erin Marner provides an overview of the PD-L1 (SP263) Assay by reviewing two urothelial carcinoma cases. Common questions are addressed and… sp263 urothelial cancer From Bharathi Vennapusa 0 likes 6 plays Content Declaration Keep for 3 Years Language (In English) English
12:14 Case Study: Assessing PD-L1 in TNBC - Select… Case Study: Assessing PD-L1 in TNBC - Select cases with staining near the scoring algorithm cut-off	Case Study: Assessing PD-L1 in TNBC - Select cases with staining near the scoring algorithm cut-off Dr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the borderline tissue staining of IC around 1% of tumor area that a pathologist will see in the… pd-l1 (sp142) From Bharathi Vennapusa 0 likes 5 plays Content Declaration Keep for 3 Years Language (In English) English
13:48 Case Study: Assessing PD-L1 in TNBC - Scoring… Case Study: Assessing PD-L1 in TNBC - Scoring cases with common staining patterns	Case Study: Assessing PD-L1 in TNBC - Scoring cases with common staining patterns Dr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the most common pattern of tissue staining a pathologist will see in the triple negative breast… pd-l1 (sp142) From Bharathi Vennapusa 0 likes 4 plays Content Declaration Keep for 3 Years Language (In English) English
10:50 Case Study: Assessing PD-L1 in TNBC. Moderate IC… Case Study: Assessing PD-L1 in TNBC. Moderate IC staining without TC staining	Case Study: Assessing PD-L1 in TNBC. Moderate IC staining without TC staining Dr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the most common tissue staining pattern a pathologist will see in the triple negative breast cancer… pd-l1 (sp142) From Bharathi Vennapusa 0 likes 7 plays Content Declaration Keep for 3 Years Language (In English) English
16:24 PD-L1 testing and SP142 assay as a diagnostic… PD-L1 testing and SP142 assay as a diagnostic tool in triple negative breast cancer (TNBC)	PD-L1 testing and SP142 assay as a diagnostic tool in triple negative breast cancer (TNBC) VENTANA PD-L1 (SP142) assay is the first and only FDA-approved assay for mTNBC. Testing for PD-L1 identifies patients who could benefit from TECENTRIQ + nab-pac in 1L mTNBC* This video is… pd-l1 (sp142) From Bharathi Vennapusa 0 likes 7 plays Content Declaration Keep for 3 Years Language (In English) English